Found 215 matching trials
SIRT With Tremelimumab and Durvalumab for Resectable HCC PHASE1 The goal of this research study is to evaluate the safety and tolerability ...
Show More Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
PolyImmune {Durvalumab (MEDI4736) and Tremelimumab} & Vaccine Orchestrated Treatment for Patients With Advanced/Metastatic Renal Cell Carcinoma PHASE2 Reported in the 2018 NEJM (378; 1277) article, the combination of checkpoin...
Show More Location
Multiple Locations
Learn More & Join Trial
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma PHASE2 The main purpose of this trial is to investigate the effects of a new class...
Show More Location
Northwestern University
Learn More & Join Trial
Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation PHASE2 This phase I/II trial studies the side effects and best dose of olaparib wh...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Cryoablation and Arterial Infusion of SD-101 in Combination With Durvalumab and Tremelimumab PHASE1 The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Show More Status
Active Not Recruiting
Location
University of California, San Diego
Learn More & Join Trial
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC PHASE1 This is an open-label, multicenter, 2-arm study to evaluate the safety and ...
Show More Location
Research Facility
Learn More & Join Trial
Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma PHASE1 A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability...
Show More Learn More & Join Trial
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach PHASE2 Combined-modality treatment of localized muscle invasive bladder cancer inc...
Show More Location
Instituto Catalán de Oncología Badalona
Learn More & Join Trial
Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer PHASE1 This phase Ib trial investigates the side effects of durvalumab and tremeli...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma EARLY_PHASE1 The primary objective of this pilot study is to assess the feasibility of m...
Show More Location
Multiple Locations
Learn More & Join Trial